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Abstract 
Natural products represent a rich source of biologically active compounds and are an 
example of molecular diversity, with recognized potential in drug discovery. Herein, 
methanol extract of Matricaria recutita L. (German chamomile) and its decoction and 
infusion (the most consumed preparations of this herb) were submitted to an analysis of 
phytochemicals and bioactivity evaluation. The antioxidant activity was determined by 
free radicals scavenging activity, reducing power and inhibition of lipid peroxidation; 
the antitumour potential was tested in human tumour cell lines (breast, lung, colon, 
cervical and hepatocellular carcinomas), and the hepatotoxicity was evaluated using a 
porcine liver primary cell culture (non-tumour cells). All the samples revealed 
antioxidant properties. Decoction had no antitumour activity (GI50>400 µg/mL) which 
could indicate that this bioactivity might be related to compounds (including phenolic 
compounds) that were not extracted or that were affected by the decoction procedure. 
Both plant methanol extract and infusion showed inhibitory activity of the growth of 
HCT-15 (GI50 250.24 and 298.23 µg/mL, respectively) and HeLa (GI50 259.36 and 
277.67 µg/mL, respectively) cell lines, without hepatotoxicity (GI50>400 µg/mL). 
Infusion and decoction gave higher contents of organic acids (24.42 and 23.35 g/100 g 
dw). Otherwise, the plant methanol extract presented the highest amounts of phenolic 
acids (3.99 g/100 g dw) and flavonoids (2.59 g/100 g dw). The major compound found 
in all the preparations was luteolin O-acylhexoside. Overall, German chamomile 
contains important phytochemicals with bioactive properties (mainly antitumour 
potential selective to colon and cervical carcinoma cell lines) to be explored in the 
medicine, food, and cosmetic industries. 
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1. Introdution 
German chamomile (Matricaria recutita L.) is an annual herbaceous flowering plant 
native to Europe. This herb has been used as herbal remedies for thousands of years 
(Crevin, 1990). It has been used traditionally as a medicinal and pharmaceutical 
preparation, due to its anti-inflammatory, anti-spasmodic, analgesic, antibacterial, anti-
allergic antioxidant and mild astringent properties, and healing medicine (Maschi et al., 
2008; McKay, & Blumberg, 2006; Weiss, 1988). Externally, chamomile has been used 
to treat diaper rash, cracked nipples, chicken pox, ear and eye infections, disorders of 
the eyes including blocked tear ducts, conjunctivitis, nasal inflammation and poison ivy 
(Srivastava, Shankar, & Gupta, 2010).  
The use of German chamomile teas as medicinal preparations has a long tradition in 
various countries. Infusions and essential oils are used in a number of commercial 
products including soaps, detergents, perfumes, lotions, ointments, hair products, baked 
goods, confections, alcoholic beverages and herbal teas (Gupta, Mittal, Bansal, Khokra, 
& Kaushik, 2010). Traditionally, chamomile flowers are prepared as an infusion with 
water, to make an herbal tea (Harbourne, Jacquier, & O’Riordan, 2009). Recent 
research supports this use and shows that these properties are partly due to the phenolic 
content (Maschi et al., 2008; McKay, & Blumberg, 2006).  
German chamomile contains several classes of biologically active compounds including 
essential oils (Granzera, Schneider, & Stuppner, 2006; Petronilho, Maraschin, Coimbra, 
& Rocha, 2012) and several polyphenols (McKay, & Blumberg, 2006; Nováková, 
Vildová, Mateus, Gonçalves, & Solich, 2010). Some phenolic compounds have the 
capacity to quench lipid peroxidation products, prevent DNA oxidative damage, and 
scavenge reactive oxygen species (ROS) such as superoxide, hydrogen peroxide and 
hydroxyl radicals (Kahkonen et al., 1999). Flavonoids are the most abundant phenolic 
compounds in herbs (Mladěnka et al., 2010) and their effects on human health are very 
often ascribed to their potential ability to act diminishing free radical steady state 
concentration in biological systems providing antioxidant protection (Galleano, 
Verstraeten, Oteiza, & Fraga, 2010). Such ability could be possible considering that 
polyphenols have chemical structures supporting the scavenging of free radicals and the 
chelation of redox-active metals. In parallel, it has been reported that certain flavonoids 
can provide benefits in pathological situations associated with high free radical 
production, (e.g. hypertension and cardiovascular disease) (Galleano et al., 2010).   
Some related studies dealing with M. recutita flowers are available in literature, 
including reports on antioxidant properties of its methanol extract (Barros, Oliveira, 
Carvalho, & Ferreira, 2010; Miliauskas,	   Venskutonis, & Beek, 2004), antitumour 
potential of aqueous and organic extracts (Strivastava & Gupta, 2007; Strivastava & 
Gupta, 2009), and phenolic composition of methanolic extracts (Mulinacci, Romani, 
Pinelli, Vincieri, & Prucher, 2000; Nováková et al., 2010). Nevertheless, studies on M. 
recutita infusion and decoction, the most consumed preparation of this herb, are scarce, 
and therefore, the present study reports the bioactive properties (antioxidant and 
antitumour activities, and hepatotoxicity), organic acids and phenolic characterization of 
wild M. recutita infusions and decoction (the most consumed preparations of this herb).  
 
2. Materials and methods 
2.1. Standards and reagents 
Acetonitrile 99.9% was of HPLC grade from Fisher Scientific (Lisbon, Portugal). The 
phenolic compound standards (chlorogenic acid; ferulic acid, luteolin-6-C-glucoside; 
luteolin-7-O-glucoside; myricetin; protocatechuic acid and quercetin 3-O-glucoside) 
were from Extrasynthese (Genay, France). 2,2-Diphenyl-1-picrylhydrazyl (DPPH) was 
obtained from Alfa Aesar (Ward Hill, MA, USA). Fetal bovine serum (FBS), L-
glutamine, Hank’s balanced salt solution (HBSS), trypsin-EDTA 
(ethylenediaminetetraacetic acid), nonessential amino acids solution (2 mM), 
penicillin/streptomycin solution (100 U/mL and 100 mg/mL, respectively), RPMI-1640 
and DMEM media were from Hyclone (Logan, USA). Acetic acid, ellipticine, 
sulforhodamine B (SRB), trypan blue, trichloroacetic acid (TCA), Tris and all organic 
acids standards (L-ascorbic acid; citric acid, fumaric acid, malic acid, shikimic acid; 
succinic acid; oxalic acid and quinic acid)	   were from Sigma Chemical Co. (Saint Louis, 
USA). Water was treated in a Milli-Q water purification system (TGI Pure Water 
Systems, USA). 
 
2.2. Sample 
Matricaria recutita flower heads and leafy flowering stems of about 15 cm long were 
collected in 2009, in late spring and early summer, in the Natural Park of Montesinho 
territory, Trás-os-Montes, North-eastern Portugal. Morphological key characters from 
Rothmaler (2007) were used for plant identification. Voucher specimens are deposited 
in the Escola Superior Agrária de Bragança herbarium (BRESA). The sample was 
lyophilized (FreeZone 4.5, Labconco, Kansas, USA), reduced to a fine dried powder (20 
mesh) and mixed to obtain homogenate sample.  
 
2.3. Infusion, decoction and methanol extract preparation 
For infusion preparation, the sample (1 g of lyophilized flowers and leafy flowering 
stems) was added to 200 mL of boiling distilled water and left to stand at room 
temperature for 5 min, and then filtered under reduced pressure. The obtained infusion 
was frozen and lyophilized. 
For decoction preparation, the sample (1 g) was added to 200 mL of distilled water, 
heated (heating plate, VELP scientific) and boiled for 5 min. The mixture was left to 
stand at room temperature for 5 min more, and then filtered under reduced pressure. The 
obtained decoction was frozen and lyophilized.  
A methanol extract was also obtained from the lyophilized plant material, and used as 
control. The sample (1 g) was extracted by stirring with 25 mL of methanol (25 ºC at 
150 rpm) for 1 h and subsequently filtered through Whatman No. 4 paper. The residue 
was then extracted with 25 mL of methanol (25 ºC at 150 rpm) for 1 h. The combined 
methanolic extracts were evaporated at 40 ºC (rotary evaporator Büchi R-210) to 
dryness.  
 
2.4. Evaluation of bioactivity  
2.4.1. Antioxidant activity.	   The lyophilized infusion and decoction, and the plant 
methanol extract were redissolved in water (final concentration 2.5 mg/mL); the final 
solution was further diluted to different concentrations to be submitted to antioxidant 
activity evaluation by in vitro assays. DPPH radical-scavenging activity was evaluated 
by using a ELX800 microplate Reader (Bio-Tek Instruments, Inc; Winooski, USA), and 
calculated as a percentage of DPPH discolouration using the formula: [(ADPPH-
AS)/ADPPH] × 100, where AS is the absorbance of the solution containing the sample at 
515 nm, and ADPPH is the absorbance of the DPPH solution (Pereira, Barros, Martins, & 
Ferreira, 2012). Reducing power was evaluated by the capacity to convert Fe3+ into 
Fe2+, measuring the absorbance at 690 nm in the microplate Reader mentioned above 
(Pereira et al., 2012). Inhibition of β-carotene bleaching was evaluated though the β-
carotene/linoleate assay; the neutralization of linoleate free radicals avoids β-carotene 
bleaching, which is measured by the formula: β-carotene absorbance after 2h of 
assay/initial absorbance) × 100 (Pereira et al., 2012). Lipid peroxidation inhibition in 
porcine (Sus scrofa) brain homogenates was evaluated by the decreasing in 
thiobarbituric acid reactive substances (TBARS); the colour intensity of the 
malondialdehyde-thiobarbituric acid (MDA-TBA) was measured by its absorbance at 
532 nm; the inhibition ratio (%) was calculated using the following formula: [(A - B)/A] 
× 100%, where A and B were the absorbance of the control and the sample solution, 
respectively (Pereira et al., 2012). The results were expressed in EC50 value (sample 
concentration providing 50% of antioxidant activity or 0.5 of absorbance in the reducing 
power assay). Trolox was used as positive control. 
 
2.4.2. Antitumour activity 
The lyophilized infusion and decoction, and the plant methanol extract were redissolved 
in water (final concentration 8 mg/mL); the final solution was further diluted to 
different concentrations to be submitted to antitumour activity in vitro evaluation. Five 
human tumour cell lines were used: MCF-7 (breast adenocarcinoma), NCI-H460 (non-
small cell lung cancer), HCT-15 (colon carcinoma), HeLa (cervical carcinoma) and 
HepG2 (hepatocellular carcinoma). Cells were routinely maintained as adherent cell 
cultures in RPMI-1640 medium containing 10% heat-inactivated FBS (MCF-7, NCI-
H460 and HCT-15) and 2 mM glutamine or in DMEM supplemented with 10% FBS, 2 
mM glutamine, 100 U/mL penicillin and 100 mg/mL streptomycin (HeLa and HepG2 
cells), at 37 ºC, in a humidified air incubator containing 5% CO2. Each cell line was 
plated at an appropriate density (7.5 × 103 cells/well for MCF-7, NCI-H460  and HCT-
15 or 1.0 × 104 cells/well for HeLa and HepG2) in 96-well plates and allowed to attach 
for 24 h. Cells were then treated for 48 h with the different diluted sample solutions. 
Following this incubation period, the adherent cells were fixed by adding cold 10% 
trichloroacetic acid (TCA, 100 µL) and incubated for 60 min at 4 ºC. Plates were then 
washed with deionized water and dried; sulforhodamine B solution (0.1% in 1% acetic 
acid, 100 µL) was then added to each plate well and incubated for 30 min at room 
temperature. Unbound SRB was removed by washing with 1% acetic acid. Plates were 
air dried, the bound SRB was solubilised with 10 mM Tris (200 µL, pH 7.4) and the 
absorbance was measured at 540 nm (Monks et al., 1991) in the microplate reader 
mentioned above. The results were expressed in GI50 values (sample concentration that 
inhibited 50% of the net cell growth). Ellipticine was used as positive control.  
 
2.4.3. Hepatotoxicity 
A cell culture was prepared from a freshly harvested porcine liver obtained from a local 
slaughter house, and it was designed as PLP2. Briefly, the liver tissues were rinsed in 
Hank’s balanced salt solution containing 100 U/mL penicillin, 100 µg/mL streptomycin 
and divided into 1×1 mm3 explants. Some of these explants were placed in 25 cm2 
tissue flasks in DMEM medium supplemented with 10% fetal bovine serum, 2 mM 
nonessential amino acids and 100 U/mL penicillin, 100 mg/mL streptomycin and 
incubated at 37 ºC with a humidified atmosphere containing 5% CO2. The medium was 
changed every two days. Cultivation of the cells was continued with direct monitoring 
every two to three days using a phase contrast microscope. Before confluence, cells 
were subcultured and plated in 96-well plates at a density of 1.0×104 cells/well, and 
cultivated in DMEM medium with 10% FBS, 100 U/mL penicillin and 100 µg/mL 
streptomycin (Abreu et al., 2011). Cells were treated for 48 h with the different diluted 
sample solutions and the same procedure described in the previous section for SRB 
assay was followed. The results were expressed in GI50 values (sample concentration 
that inhibited 50% of the net cell growth). Ellipticine was used as positive control.  
 2.5. Analysis of organic acids  
Organic acids were determined following a procedure previously optimized and 
described by the authors (Barros, Pereira, & Ferreira, 2012). Analysis was performed by 
ultra fast liquid chromatograph (UFLC) coupled to photodiode array detector (PDA), 
using a Shimadzu 20A series UFLC (Shimadzu Cooperation). Detection was carried out 
in a PDA, using 215 nm and 245 as preferred wavelengths. The organic acids were 
quantified by comparison of the area of their peaks recorded at 215 nm with calibration 
curves obtained from commercial standards of each compound. The results were 
expressed in g per 100 g of dry weight (dw). 
 
2.6. Analysis of phenolic compounds 
Phenolic compounds were determined by HPLC (Hewlett-Packard 1100, Agilent 
Technologies, Santa Clara, USA) as previously described by the authors (Barros et al., 
2012). Double online detection was carried out in the diode array detector (DAD) using 
280 nm and 370 nm as preferred wavelengths and in a mass spectrometer (MS) 
connected to the HPLC system via the DAD cell outlet. The phenolic compounds were 
characterized according to their UV and mass spectra and retention times, and 
comparison with authentic standards when available. For quantitative analysis, 
calibration curves were prepared from different standard compounds. The results were 
expressed in g per 100 g of dry weight (dw). 
 
2.7 Statistical analysis.  
All the assays were carried out in triplicate in three different samples of infusion, 
decoction and plant methanol extract; the results of bioactivity (antioxidant and 
antitumour activities, and hepatotoxicity) and of organic acids and phenolic compounds 
composition are expressed as mean values±standard deviation (SD). The statistical 
differences represented by letters were obtained through one-way analysis of variance 
(ANOVA) followed by Tukey’s honestly significant difference post hoc test with α = 
0.05. These treatments were carried out using SPSS v. 18.0 program.   
 
3. Results and Discussion 
3.1. Evaluation of bioactivity 
The antioxidant activity was determined by free radicals scavenging activity, reducing 
power and inhibition of lipid peroxidation in brain cell homogenates, the antitumour 
potential was tested in human tumour cell lines (breast, lung, colon, cervical and 
hepatocellular carcinomas), and the hepatotoxicity was evaluated using a porcine liver 
primary cell culture. The results are shown in Table 1. 
The infusion and decoction lyophilized samples gave similar antioxidant activity 
properties and were better than the plant methanol extract in the radical scavenging 
assays (DPPH and β-carotene bleaching inhibition). Otherwise, the plant methanol 
extract gave higher reducing power and lipid peroxidation inhibition measured by 
TBARS assay (lowest EC50 values). The mechanisms involved in the assays used to 
evaluate antioxidant activity are different and, therefore, each plant preparation can 
have different compounds with specific capacities to participate in those mechanisms. 
Trolox and ellipticine were used as positive controls of antioxidant and antitumour 
activities evaluation assays, but should not be considered as standards and the 
comparison with extracts/oral preparations results should be avoided, because they are 
individual compounds and not mixtures. 
Regarding antitumour effects, M. recutita infusion and plant methanol extract showed to 
be selective for HCT-15 and HeLa, since no activity was observed against the other cell 
lines: MCF-7, NCI-H460 and HepG2. Nevertheless, none of the M. recutita 
preparations showed hepatotoxicity in the porcine liver primary cell culture (non-
tumour cells; PLP2) (Table 1). The plant methanol extract was slightly more potent 
than the infusion sample in HCT-15 and HeLa human cell lines. Decoction preparation 
had no antitumour effects at the maximal concentration used (400 µg/mL). The results 
obtained are in agreement with other authors that reported minimal growth inhibitory 
effects in normal cells, but a significant reduction in cell viability in various human 
cancer cell lines, mainly from methanolic fractions rather than aqueous ones (Srivastava 
& Gupta, 2007, 2009). The absence of antitumour activity in decoction of another 
chamomile species, Chamaemelum nobile (Roman chamomile), was previously 
reported by us (Guimarães et al., 2012). 
It should be highlighted that M. recutita has been included in commercial mixtures for 
different pharmacological applications such as i) TBS-101 (a mixture of seven 
standardized botanical extracts) that showed an outstanding safety profile with 
significant anticancer activity against androgen-refractory human prostate cancer PC-3 
cells, both in vitro and in vivo (Evans, Dizeyi, Abrahamsson, & Persson, 2009); ii) STW 
5 (a mixture of nine standardized botanical extracts) for treatment of gastrointestinal 
disorders, with a mechanism of action related to their antioxidant properties (Schempp, 
Schempp, Weiser, Kelber, & Elstner, 2006). Nevertheless, chemical characterization 
and bioactivity evaluation of M. recutita infusion and decoction, the most consumed 
preparations of this herb, have been discarded being addressed herein.  
 
3.2. Analysis of organic acids and phenolic compounds  
Oxalic, quinic, malic, citric and succinic acids were quantified in all the extracts of M. 
recutita, malic acid being the most abundant organic acid (Table 2). Shikimic and 
fumaric acids were present in low or vestigial amounts. Ascorbic acid was not detected 
neither in infusion nor decoction, and was present in traces in the plant extract. Infusion 
and decoction gave similar contents in organic acids, and higher than the plant extract.  
Organic acids might have antioxidant properties, such is the case of citric and oxalic 
acids (Hraš, Halodin, Knez, & Bauman, 2000; Kayashima & Katayama, 2002), which 
may contribute for the antioxidant activity of the samples studied herein. 
The main phenolic compounds found in M. recutita plant and in its decoction and 
infusion were phenolic acids and derivatives, as also flavonoids such as flavonols and 
flavones (Tables 3 and 4). The chromatographic profile of the three plant preparations 
can be observed in Figure 1. Up to twenty phenolic compounds, including phenolic 
acids and flavonoids were detected in the M. recutita preparations (Table 3). 
Compound 2 was identified as protocatechuic acid by comparison of its UV spectrum 
and retention time with a commercial standard. Thirteen hydroxycinnamic acid 
derivatives (peaks 1, 3-9, 11, 12, 14, 16 and 19) were detected, ten being quinic acid 
derivatives (1, 3-6; 9, 12, 14, 16 and 19), whose identities were assigned based on their 
MS spectra and fragmentation patterns. These compounds released characteristic MS2 
fragment ions at m/z 191 (deprotonated quinic acid), 179 (deprotonated caffeic acid) or 
193 (deprotonated ferulic acid), which together with their pseudo molecular ions [M-H]- 
at m/z 353, 515, 677 or 367 allowed their identification as quinic acid derivatives 
containing one, two or three caffeic acid moieties or one ferulic acid moiety, 
respectively. The assignments of the different caffeoylquinic acid isomers were made 
using the recommended IUPAC numbering system, as also the hierarchical keys 
previously developed by Clifford, Johnston, Knight, & Kuhnert (2003) and Clifford, 
Knight, & Kuhnert (2005).  
Compound 6 was positively identified as 5-O-caffeoylquinic acid by comparison with 
an authentic standard, as also to its MS fragmentation pattern. Compound 5 was 
tentatively assigned as the corresponding	   cis isomer of 5-O-caffeoylquinic acid based 
on its fragmentation pattern and lower levels compared with peak 6. Furthermore, 
hydroxycinnamoyl cis derivatives would be expected to elute before the corresponding 
trans ones, as observed after UV irradiation (366 nm, 24 h) of hydroxycinnamic acids in 
our laboratory. 
Compound 1 ([M-H]- at m/z 353) was identified as 3-O-caffeoylquinic acid, yielding the 
base peak at m/z 191 and the ion at m/z 179 with an intensity >55% base peak, 
characteristic of 3-acylchlorogenic acids as reported by Clifford et al. (2003, 2005).  
Compound 4 was easily distinguished from the other two isomers by its base peak at 
m/z 173 [quinic acid-H-H2O]-, accompanied by a secondary fragment ion at m/z 179 
with approximately 84% abundance of base peak, which allowed identifying it as 4-O-
caffeoylquinic acid according to the fragmentation pattern described by Clifford et al. 
(2003, 2005). Compound 9 was tentatively identified as 5-O-feruloylquinic acid taking 
into account its fragmentation pattern and relative intensities similar to 5-O-
caffeoylquinic acid. 
Compounds 3, 14, 16 and 19 ([M-H]- at m/z 515) could be assigned as dicaffeoylquinic 
acids and were assigned to 1,5-O-, 3,4-O-, 3,5-O- and 4,5-O- dicaffeoylquinic acids, 
respectively, based on their elution order, fragmentation pattern and relative abundances 
(Clifford et al., 2003, 2005). MS2 fragmentation of compound 14 yielded the formation 
of signals corresponding to “dehydrated” fragment ions at m/z 335 [caffeoylquinic acid 
–H-H2O]- and m/z 173 [quinic acid-H-H2O]-, characteristic of 4-acyl-caffeoylquinic 
acids. Furthermore, according to Clifford et al. (2005), the intensity of signal at m/z 335 
(25% of base peak) is more intense than in 4,5-O-dicaffeoylquinic (barely detectable, 
4% of base peak). These observations allowed assigning compound 14 as 3,4-O-
dicaffeoylquinic acid. The fragmentation pattern for 3,5-O-dicaffeoylquinic (compound 
16) acid was similar to the one previously reported by Clifford et al. (2005). MS2 base 
peak was at m/z 353, produced by the loss of one of the caffeoyl moieties [M-H-
caffeoyl]-, and subsequent fragmentation of this ion yielded the same fragments as 5-
caffeoylquinic acid at m/z 191, 179 and 135, although in this case with a comparatively 
more intense signal at m/z 179 [caffeic acid-H]-  (75% base peak). Compound 19 was 
assigned to 4,5-O- dicaffeoylquinic acid since its fragmentation was identical to those 
previously reported by Clifford et al. (2005). In this case, the signal at m/z 335 was 
barely detectable (<5 % of base peak) and the intense signal at m/z 173, is characteristic 
for an isomer substituted at position 4, which indicated that whereas 3,4-O-
dicaffeoylquinic acid initially loses the caffeoyl moiety at position 3, in the case of 4,5-
O-dicaffeoylquinic acid would initially lose that at position 5. Compound 3 was 
assigned as 1,5-O-dicaffeoylquinic acid, following the criteria the reported by Clifford 
et al. (2005), the weak ions at m/z 335 and 179 (<10 % of base peak).  
Compound 12 was identified as tricaffeoylquinic acid according to its pseudomolecular 
ion [M-H]- at m/z 677 and diagnostic MS2 fragments at m/z 515 (loss of the first 
caffeoyl), m/z 353 (loss of the second caffeoyl), m/z 191 (loss of the third caffeoyl to 
give quinic acid ion), m/z 179 (caffeic acid ion). The signal observed at m/z 497 can be 
interpreted by the loss of a water molecule from the ion at m/z 515. According to the 
relative intensities of different tricaffeoylquinic acid isomers reported by Lin & Harnly 
(2008), this compound could be assigned as 1,3,5-O-tricaffeoylquinic acid or 1,4,5-O-
tricaffeoylquinic acid.  
Compounds 7 and 8 with MS2 fragments at m/z 193 ([ferulic acid-H]-) resulting from the 
loss of a hexosyl moiety, -162 mu, and 176 ([ferulic acid-H-H2O]-) was tentatively 
assigned as a ferulic acid hexoside. Compound 7 presented similar UV and mass spectra 
characteristics as peak 8 but an earlier retention time, taking into account the 
observation above it was tentatively identified as cis ferulic acid hexoside. Similarly, 
compound 11 was tentatively identified as ferulic acid hexoside dimer.  
 Flavones were the most abundant flavonoids present in the samples analysed (Tables 3 
and 4).  
Compounds 13, 15, 18 and 20 were identified as luteolin derivatives. Compounds 15, 18 
and 20 presented a pseudomolecular ions [M-H]- at m/z 447 and 489 releasing a 
common MS2 fragment at m/z 285 ([M-H-162]- and [M-H-42-162]-, loss of hexosyl and 
acetylhexoside moieties, respectively). They were tentatively identified as luteolin 7-O-
glucoside (retention time compared with a commercial standard), and two luteolin O-
acetylhexoside (compound 18 and 20), respectively. Compound 13 presented a 
pseudomolecular ion [M-H]- at m/z 651 releasing three MS2 fragments at m/z 489, 447 
and 285 (loss of hexosyl, acetylhexosyl and acetyldihexosyl moieties, respectively), 
being tentatively identified as luteolin acetylhexoside hexoside. 
Flavonols (compounds 10 and 17) were also found in the studied samples (Table 3). 
Compound 10 presented a pseudomolecular ion [M-H]- at m/z 479, releasing an MS2 
fragment at m/z 317 ([M-H-162]-, loss of an hexosyl moiety), corresponding to 
myricetin, which allowed a tentative identification of the compound as myricetin O-
hexoside. Compound 17 corresponded to a quercetin derivative presenting a 
pseudomolecular ion [M-H]- at m/z 505 releasing an MS2 fragment at m/z 301 
(quercetin; [M-H-42-162]-, loss of an acetylhexoside moiety). It is known that the 
introduction of a glycoside on the hydroxyls at positions 7, 3´ or 4´ has no effect on 
wavelength maxima or the spectrum shape in relation to the aglycone (Mabry, 
Markham, & Thomas, 1970). Thus, quercetin 7-O-glycosides would have λmax in Band I 
around 370 nm, while quercetin 3 O-glycosides are hypsochromically shifted to around 
354 nm. Since this compound presented λmax at 372 nm it was tentatively identified as 
quercetin 7-O-acetylhexoside. 
The amounts of the phenolic compounds found varied among the different preparations 
and flavonols decreased in infusions and decoctions, but otherwise cis isomer of 
caffeoylquinic and ferulic acids derivatives appeared in these preparations (Table 4 and 
Figure 1). The plant methanol extract (control) presented the highest amounts of 
phenolic acids (3.99 g/100 g dw) and flavonoids (2.59 g/100 g dw) as also total phenolic 
compounds (6.58 g/100 g dw), followed by infusion (5.00 g/100 g dw) and decoctions 
(3.51 g/100 g dw). The same was observed in Chamaemelum nobile (Roman 
chamomile) in a previously work of our research group (Guimarães et al., 2012). 
The major compound found in the herbal plant and in the preparations was luteolin O-
acylhexoside (compound 20). Mulinacci et al. (2000), Nováková et al. (2010), 
Harbourne et al., (2009) and Srivastava & Gupta, (2009) reported the presence of 
apigenin 7-O-glucoside and other apigenin derivatives, but these compounds were not 
detected in our samples. 
Furthermore, Mulinacci et al. (2000) revealed the presence of different flavonoids, such 
as patuletin and other quercetin derivatives. In relation to the quantification, no 
comparison can be made, due to the fact that those authors only presented percent area 
measured at 335 nm of the main phenolic compounds found.    
Nováková et al. (2010) presented the phenolic profile of methanolic extracts of M. 
recutita herbal flowers and infusions, demonstrating also lower values in infusions 
preparation when compared to the herbal plant methanolic extract. These authors also 
found a dissimilar profile than the one obtained in this study, finding other flavonoids, 
such as kaempferol, isorhamnetin and different quercetin derivatives in their samples. 
The quantification was expressed in µmol/L, being difficult to compare with the results 
of M. recutita obtained herein.  
 
Overall, it was observed a decrease in the amount of phenolic compounds in the plant 
infusion or decoction, compared to the methanol extract; the same was not observed for 
organic acids, which indicates that these compounds are better extracted with hot water 
than with methanol. The decoction had no antitumour effects which could indicate that 
these effects might be related to compounds (including phenolic compounds) that were 
not extracted or that were affected by the decoction procedure. Both plant methanol 
extract and infusion showed inhibitory activity of the growth of colon and cervical 
carcinoma cell lines, without toxicity for hepatocyte normal cells. Therefore, wild 
German chamomile (M. recutita) may be considered a source of important 
phytochemicals with bioactive properties to be explored in the medicine, food, and 
cosmetic industries. 
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Table 1. Antioxidant and antitumour activities, and hepatotoxicity of wild Matricaria 
recutita (mean ± SD). 
*Results reported in Barros et al., 2010. **Trolox and ellipticine for antioxidant and 
antitumour activity assays, respectively. EC50 values correspond to the sample 
concentration achieving 50% of antioxidant activity or 0.5 of absorbance in reducing 
power assay. GI50 values correspond to the sample concentration achieving 50% of 
growth inhibition in human tumour cell lines or in liver primary culture PLP2. In each 
row different letters mean significant differences (p<0.05). 
 
 
 
 
 
 
 Infusion Decoction Plant methanol extract* Positive control** 
Extraction yield (%)  16.25 ± 0.59 19.37 ± 1.09 16.09 ± 0.77 - 
Antioxidant activity (EC50 values, µg/mL)     
DPPH scavenging activity  394.97 ± 44.31b 344.02 ± 18.65b 800.36 ± 49.09a  43.03 ± 1.71	  
Reducing power  316.61 ± 2.46a 318.75 ± 3.01a 232.49 ± 26.19b 29.62 ± 3.15  
β-carotene bleaching inhibition  422.72 ± 92.91b 497.34 ± 107.67b 661.11 ± 21.93a   2.63 ± 0.14  
TBARS inhibition  511.01 ± 17.28a 508.44 ± 4.43a 183.48 ± 3.52b   3.73 ± 1.90  
Antitumour activity (GI50 values, µg/mL) Infusion Decoction Plant methanol extract Positive control** 
MCF-7 (breast carcinoma) >400 >400 >400 0.91±0.04	  
NCI-H460 (non-small lung cancer) >400 >400 >400 1.42±0.00	  
HCT-15 (colon carcinoma) 298.23±11.58a >400 250.24±18.38b 1.91±0.06 
HeLa (cervical carcinoma) 277.67±9.04a >400 259.36±7.57b 1.14±0.21	  
HepG2 (hepatocellular carcinoma) >400 >400 >400 3.22±0.67	  
Hepatotoxicity (GI50 value, µg/mL)     
PLP2 >400 >400 >400 2.06±0.03 
Table 2. Identification and quantification of organic acids in wild Matricaria recutita 
(mean ± SD).  
Organic acid Infusion Decoction Plant (control) 
Oxalic acid 8.45 ± 0.32a 8.60 ± 0.47a 3.24 ± 0.05b 
Quinic acid 0.24 ± 0.00b 0.88 ± 0.19a 0.17 ± 0.00c 
Malic acid 2.26 ± 0.06a 1.97 ± 0.03b 0.39 ± 0.02c 
Shikimic acid 0.02 ± 0.00 0.02 ± 0.00 tr 
Ascorbic acid nd nd tr 
Citric acid 6.44 ± 0.85a 6.14 ± 0.14a 1.55 ± 0.00b 
Succinic acid 7.00 ± 0.21a 5.74 ± 0.13b 1.94 ± 0.05c 
Fumaric acid    0.01 ± 0.00 0.01 ± 0.00 tr  
Total (g/100 g dw) 24.42 ± 1.32a 23.35 ±0.65a 7.30 ± 0.03b 
In each row different letters mean significant differences (p<0.05); tr- traces; nd-not 
detected; dw- dry weight. 
 
 
 
 
 
 
 Table 3. Retention time (Rt), wavelengths of maximum absorption in the UV-vis region (λmax), pseudomolecular and MS2 fragment ions (in 
brackets, relative abundances) and tentative identification of the phenolic compounds of wild Matricaria recutita. 
Peak Rt (min) 
λmax 
 (nm) 
Molecular ion  
[M-H]- (m/z) 
MS2 
(m/z) Tentative identification 
1 7.69 328 353 191(100), 179(53), 173(5), 161(5), 135(48) 3-O-caffeolyquinic acid 
2 8.24 294 153 109(100) Protocatechuic acid 
3 9.75 320 515 515(100),353(5), 191(33), 179(6), 161(13) 1,5-Dicaffeolyquinic acid 
4 10.84 326 353 191(75), 179(84), 173(100), 161(11), 135(77) 4-O-Caffeolyquinic acid 
5 11.34 326  353  191(100), 179(7), 173(3), 161(4), 135(2) cis-5-O-Caffeolyquinic acid 
6 11.57 326 353 191(100), 179(15), 173(8), 161(15), 135(7) trans-5-O-Caffeolyquinic acid 
7 12.24 312 355 193(100), 179(13), 149(80) cis-Ferulic acid  hexoside 
8 12.39 312 355 193(100), 179(13), 149(81) trans-Ferulic acid hexoside 
9 14.85 328 367 193(16), 191(100), 173(19), 134(8)  5-O-Feruloylquinic acid 
10 15.18 354 479 317(100) Myricetin O-hexoside 
11 15.45 322 711 549(3), 355(36), 193(100), 149(84) Ferulic acid  hexoside dimer 
12 15.81 322 677 515(100), 497(2), 353(17), 335(7), 191(4), 179 (7), 173 (1), 135 (3)  1,3,5-O or 1,4,5-O-Tricaffeolyquinic  
13 16.54 340 651 489(96), 447(55), 285(45) Luteolin acetylhexoside hexoside 
14 17.11 330 515 515 (100),353(66), 335(25),299(2),255(3),203(3),191(26),179(53),173(68), 161(9)  3,4-O-Dicaffeolyquinic acid 
15 17.68 340 447 285(100) Luteolin-7-O-glucoside 
16 18.09 330 515 353(100),335(8),191(89),179(75),173(11),161(7), 155(2),135(28)  3,5-O-Dicaffeolyquinic acid 
17 18.54 372 505 343(8), 301(100) Quercetin 7-O-acetylhexoside  
18 18.64 343 489  327(5), 285(64) Luteolin O-acylhexoside 
19 18.81 328 515 353(100),335(4),299(5),255(5),203(3),191(30),179(67), 173(95), 161(2),155(3),135(24) 4,5-O-Dicaffeoylquinic acid  
20 19.10 296(sh),336 489 327(5), 285(64) Luteolin O-acylhexoside 
Table 4. Quantification of phenolic compounds in wild Matricaria recutita (mean ± 
SD). 
Peak Infusion Decoction Plant (control) 
3-O-caffeolyquinic acid 0.15 ± 0.01a 0.12 ± 0.00b 0.07 ± 0.00c 
Protocatechuic acid 0.07 ± 0.01a 0.05 ± 0.01b nd 
1,5-Dicaffeolyquinic acid nd tr 0.02 ± 0.00 
4-O-Caffeolyquinic acid 0.21 ± 0.00b 0.13 ± 0.00c 0.24 ± 0.00a 
cis 5-O-Caffeolyquinic acid 0.17 ± 0.04a 0.15 ± 0.00a nd 
trans 5-O-Caffeolyquinic acid 0.26 ± 0.04b 0.22 ± 0.01b 1.02 ± 0.02a 
cis Feruloyl hexoside acid  0.32 ± 0.02a 0.28 ± 0.01b nd 
trans  Feruloyl hexoside acid 0.46 ± 0.01b 0.38 ± 0.01c 1.02 ± 0.00a 
5-O-Feruloylquinic acid 0.03 ± 0.00a 0.02 ± 0.00b nd 
Myricetin O-hexoside nd nd 0.05 ± 0.00 
Feruloyl hexoside acid dimer 0.59 ± 0.00b 0.55 ± 0.01c 0.91 ± 0.00a 
1,3,5-O or 1,4,5-Tricaffeolyquinic  0.03 ± 0.00b 0.02 ± 0.00c 0.06 ± 0.00a 
Luteolin acetylhexoside hexoside 0.02 ± 0.00c 0.03 ± 0.00b 0.11 ± 0.01a 
3,4-O-Dicaffeolyquinic acid 0.73 ± 0.03a 0.33 ± 0.01b 0.35 ± 0.00b 
Luteolin-7-O-glucoside 0.17 ± 0.01a 0.09 ± 0.00b 0.06 ± 0.00c  
3,5-O-Dicaffeolyquinic acid 0.26 ± 0.07a 0.16 ± 0.00b 0.10 ± 0.00b 
Quercetin 7-O-acetylhexoside  nd nd 0.10 ± 0.00 
Luteolin O-acylhexoside 0.09 ± 0.01b  0.06 ± 0.00c 0.19 ± 0.01a 
4,5-O-Dicaffeoylquinic acid  0.17 ± 0.03a 0.13 ± 0.01b nd 
Luteolin O-acylhexoside 1.29 ± 0.12b 0.81 ± 0.04c 2.10 ± 0.00a 
Total phenolic acids (g/100 g dw) 3.43 ± 0.22b	   2.53 ± 0.02c	   3.99 ± 0.02a 
Total flavonoids (g/100 g dw) 1.56 ± 0.12b	   0.98 ± 0.04c	   2.59 ± 0.01a 
Total phenolic compounds (g/100 g dw) 5.00 ± 0.33b 	   3.51 ± 0.06c	   6.58 ± 0.03a  
In each row different letters mean significant differences (p<0.05); tr- traces; nd-not 
detected; dw- dry weight. 
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Figure 1. HPLC chromatogram of the phenolic compounds of Matricaria recutita 
recorded at 280 nm (A) plant methanol extract (control; 1:2 v/v); (B) infusion and (C) 
decoction. 
